Families with children treated for ALL often face catastrophic financial toxicity, including severe income loss and inability to afford basic needs. Financial strain typically intensifies six months ...

Fixed-duration venetoclax regimens showed non-inferior progression-free survival compared to continuous ibrutinib in CLL ...

Continuous variable modeling such as the Hodgkin lymphoma international prognostic index (A-HIPI) improves prognostic ...

Investigational obesity medicine maridebart cafraglutide (Amgen) showed clinically meaningful and dose-dependent weight loss among adults with obesity, with or without type 2 diabetes (T2D), according ...

Patients with polycythemia vera (PV) taking the investigational therapy rusfertide were able to largely maintain hematocrit control and avoid the need for phlebotomy over 52 weeks, according to ...